戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  with regard to both UDP-galactose and UDP-N-acetylgalactosamine.
2 plete loss of activity with respect to UDP-N-acetylgalactosamine.
3 cific lectin and shows little affinity for N-acetylgalactosamine.
4 substrates UDP-N-acetylglucosamine and UDP-N-acetylgalactosamine.
5 lucose, galactose, N-acetylglucosamine and N-acetylgalactosamine.
6 -5'-[P1-32P]triphosphate, an analog of UDP-N-acetylgalactosamine.
7 e and partially reduced with regard to UDP-N-acetylgalactosamine.
8 atives of 2,4-diacetamidobacillosamine and N-acetylgalactosamine.
9 no sugars, UDP N-acetylglucosamine and UDP N-acetylgalactosamine.
10 acetylglucosamine, mannose, galactose, and N-acetylgalactosamine.
11 d was inhibited by N-acetylglucosamine and N-acetylgalactosamine.
12 rate UDP-N-acetylglucosamine or isomer UDP-N-acetylgalactosamine.
13 osamine to generate undecaprenyl phosphate-N-acetylgalactosamine.
14 actose, UDP- N-acetylglucosamine, and UDP- N-acetylgalactosamine.
15  characterized by a terminal or sialylated N-acetylgalactosamine.
16  glycan ligands that include galactose and N-acetylgalactosamine.
17 hree rhamnose residues and a protein-bound N-acetylgalactosamine.
18  discriminated for N-acetylglucosamine and N-acetylgalactosamine.
19 ), N-acetylglucosamine (2.27 nmol/mg), and N-acetylgalactosamine (0.652 nmol/mg).
20  Eight N-acetylglucosamine-1-phosphate and N-acetylgalactosamine-1-phosphate analogs have been synthe
21 eficient activity of arylsulfatase B (ASB; N-acetylgalactosamine 4-sulfatase) and the subsequent accu
22 iency of the enzyme arylsulfatase B (ARSB; N-acetylgalactosamine 4-sulfatase), either innate or acqui
23 matan sulfate preparations, we showed that N-acetylgalactosamine-4-O-sulfate residues are required fo
24        CHST8 encodes a Golgi transmembrane N-acetylgalactosamine-4-O-sulfotransferase (GalNAc4-ST1),
25 ntity with HNK-1 sulfotransferase (21.4%), N-acetylgalactosamine-4-O-sulfotransferase 1 (GalNAc-4-ST1
26 sulfotransferase 1 (GalNAc-4-ST1) (24.7%), N-acetylgalactosamine-4-O-sulfotransferase 2 (GalNAc-4-ST2
27    We have identified and characterized an N-acetylgalactosamine-4-O-sulfotransferase designated derm
28                     The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB))
29 -l-iduronidase, iduronate-2-sulfatase, and N-acetylgalactosamine-4-sulfatase that are used for newbor
30 ivity of the enzyme arylsulfatase B (ARSB; N-acetylgalactosamine-4-sulfatase).
31                           Arylsulfatase B (N-acetylgalactosamine-4-sulfatase; ARSB) removes 4-sulfate
32 al exohydrolase, cleaving sulfate from the N-acetylgalactosamine-4-sulfate (GalNAc-4S) residue at the
33                         We have cloned the N-acetylgalactosamine-4-sulfotransferase (GalNAc-4-ST1, Ge
34 samine (4FGlcNAc) and UDP-4-deoxy-4-fluoro-N-acetylgalactosamine (4FGalNAc), were prepared using both
35 tosamine-6-sulfatase (GALNS, also known as N-acetylgalactosamine-6-sulfatase and GalN6S; E.C. 3.1.6.4
36 s an autosomal recessive disease caused by N-acetylgalactosamine-6-sulfate sulfatase (GALNS) deficien
37 cessive disorder caused by a deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS), a lysos
38 cessive disorder caused by a deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS), leading
39 glucose, 3-deoxy-D-manno-octulosonic acid, N-acetylgalactosamine, 8-epi-legionaminic acid, phosphate,
40 nsist mostly of core 1 alpha2,6 sialylated N-acetylgalactosamine, a configuration suspected to preven
41 en-Friedenreich antigen (galactose beta1-3 N-acetylgalactosamine alpha-), we have found that this lec
42       This truncated antigen has the sugar N-acetylgalactosamine alpha-linked to either a serine or t
43 on the presence of multiple O-linked alpha-N-acetylgalactosamine (alpha-GalNAc) determinants.
44 agglutin (HPA)) with specificity for alpha-N-acetylgalactosamine (alpha-GalNAc), an epitope displayed
45         The sulfate portions of 4-sulfated-N-acetylgalactosamine and an unidentified ligand found in
46 rssman (Fs) antigen terminates with alpha3-N-acetylgalactosamine and can be used by pathogens as a ho
47 sponsible for the uptake and metabolism of N-acetylgalactosamine and galactosamine in Escherichia col
48 use DBP carries a disaccharide composed of N-acetylgalactosamine and galactose.
49 eful for the synthesis of [32P]5-azido-UDP-N-acetylgalactosamine and high-specific-activity [3H] or [
50 ly acetylated 1-->4 glycosidic linkages of N-acetylgalactosamine and N-acetylglucosamine.
51 Ac translocator has lower affinity for UDP-N-acetylgalactosamine and UDP-glucose than for its cognate
52 er can catalyze the interconversion of UDP-N-acetylgalactosamine and UDP-N-acetylglucosamine while th
53 art, mammalian GALE also interconverts UDP-N-acetylgalactosamine and UDP-N-acetylglucosamine.
54 rconverts a larger pair of substrates: UDP-N-acetylgalactosamine and UDP-N-acetylglucosamine.
55 -galactose and UDP-glucose, as well as UDP-N-acetylgalactosamine and UDP-N-acetylglucosamine.
56 eric monosaccharides, N-acetylglucosamine, N-acetylgalactosamine, and N-acetylmannosamine.
57 ining the addition of phosphoethanolamine, N-acetylgalactosamine, and N-acetylneuraminic acid.
58 finity purified on immobilized lactose and N-acetylgalactosamine, and N-glycosylated but not glycosid
59 SQV-7 transported UDP-glucuronic acid, UDP-N-acetylgalactosamine, and UDP-galactose (Gal) in a temper
60 e form of LD, express a unique glycan with N-acetylgalactosamine as a terminal sugar.
61 -acetylglucosamine or uridine 5'-diphospho-N-acetylgalactosamine as substrates but will accept uridin
62 owever, the enzyme preferentially utilized N-acetylgalactosamine as the donor for all three acceptors
63 that bear uronic acid linked to unsulfated N-acetylgalactosamine as the initial disaccharide in the C
64 crophage activating factor, a protein with N-acetylgalactosamine as the remaining sugar moiety.
65 ein (DBP) to yield the MAF, a protein with N-acetylgalactosamine as the remaining sugar.
66 including fucose, N-acetylglucosamine, and N-acetylgalactosamine as well as the yeast polysaccharide
67 Cys-MR alone and complexed with 4-sulfated-N-acetylgalactosamine at 1.7 and 2.2 A resolution, respect
68   Phosphorylated O-mannosyl trisaccharide [N-acetylgalactosamine-beta3-N-acetylglucosamine-beta4-(pho
69 st that it is a good model for the natural N-acetylgalactosamine binding site of the asialoglycoprote
70  cleaves cell surface galactose-binding or N-acetylgalactosamine-binding (Gal/Gal-NAc) lectins.
71 rotein reporter showed that it transferred N-acetylgalactosamine, but no detectable galactose or N-ac
72 howed that the purified enzyme transferred N-acetylgalactosamine, but no detectable galactose or N-ac
73 ise fashion beginning with the addition of N-acetylgalactosamine by the enzyme N-acetylgalactosaminyl
74 D displays 40-fold preferential binding to N-acetylgalactosamine compared with galactose, making it a
75 fold increase in the relative affinity for N-acetylgalactosamine compared with galactose.
76 n family, displays preferential binding to N-acetylgalactosamine compared with galactose.
77 g or 4 mg/kg RG-101, a hepatocyte targeted N-acetylgalactosamine conjugated anti-miR-122 oligonucleot
78 ngle dose of RG-101, a hepatocyte targeted N-acetylgalactosamine conjugated oligonucleotide that anta
79                  Treatment with RG-101, an N-acetylgalactosamine-conjugated anti-microRNA-122 oligonu
80  followed 24 hours later by a biotinylated N-acetylgalactosamine-containing "clearing agent" and fina
81 ministered sequentially with a dendrimeric N-acetylgalactosamine-containing clearing agent and radiol
82 reptavidin (SA) conjugates, followed by an N-acetylgalactosamine dendrimeric clearing agent and radio
83 lycan consisting of repeating uronic acid, N-acetylgalactosamine disaccharide units {[HexAbeta/alpha(
84 sporter of UDP-N-acetylglucosamine and UDP-N-acetylgalactosamine encoded by the Caenorhabditis elegan
85 f a melittin-derived peptide conjugated to N-acetylgalactosamine for hepatocyte targeting and endosom
86  first enzyme required for biosynthesis of N-acetylgalactosamine, for the major cyst wall polysacchar
87 e Fml adhesin FmlH binds galactose beta1-3 N-acetylgalactosamine found in core-1 and -2 O-glycans.
88 ansfer reaction of N-acetylglucosamine and N-acetylgalactosamine from the respective UDP-sugars to th
89 lycans by catalyzing the transfer of alpha-N-acetylgalactosamine from UDP-GalNAc to Ser or Thr residu
90 parvum sporozoites to the sugar, galactose-N-acetylgalactosamine (Gal/GalNAc), and to bovine mucin re
91 ne DBP carries a trisaccharide composed of N-acetylgalactosamine, galactose, and sialic acid, whereas
92 glycosidase that cleaves galactose beta1-3 N-acetylgalactosamine (Galbeta1-3GalNAc) from core-1 O-lin
93 tigen is a disaccharide, galactose beta1-3 N-acetylgalactosamine (Galbeta1-3GalNAc), expressed on the
94 WbiP could readily glycosylate a series of N-acetylgalactosamine (GalNAc) analogues with alpha-substi
95 roduce a polysaccharide capsule containing N-acetylgalactosamine (GalNAc) and beta-3-deoxy-d-manno-oc
96 t tx5a contains a disaccharide composed of N-acetylgalactosamine (GalNAc) and galactose (Gal), but th
97 residues: one fucose (Fuc) and two each of N-acetylgalactosamine (GalNAc) and galactose (Gal).
98 e production of both UDP-galactose and UDP-N-acetylgalactosamine (GalNAc) and is required for the pro
99 ne reproductive tract mucins, and terminal N-acetylgalactosamine (GalNAc) and sulfated carbohydrates
100    Chemical analyses confirmed the loss of N-acetylgalactosamine (GalNAc) and the presence of NeuNAc
101 his protocol, N-acetylglucosamine (GlcNAc)/N-acetylgalactosamine (GalNAc) are phosphorylated by N-ace
102 oglycoprotein receptor ligand derived from N-acetylgalactosamine (GalNAc) facilitates targeted delive
103 osynthesis is initiated by the transfer of N-acetylgalactosamine (GalNAc) from a nucleotide sugar don
104 occurring glycoconjugate motifs containing N-acetylgalactosamine (GalNAc) from the cheaper and commer
105 opolymer: chitin in Entamoeba and a unique N-acetylgalactosamine (GalNAc) homopolymer in Giardia.
106  We found that not only galactose but also N-acetylgalactosamine (GalNAc) is an efficient competitor
107  recognizes the sugars galactose (Gal) and N-acetylgalactosamine (GalNAc) on the surface of host cell
108 , like FS, catalyze the addition of either N-acetylgalactosamine (GalNAc) or galactose (Gal) in alpha
109 1-->3 glycosidic linkage to the core alpha-N-acetylgalactosamine (GalNAc) residue.
110 ed to the BclA protein backbone through an N-acetylgalactosamine (GalNAc) residue.
111 ining IgA1 and IgG antibodies specific for N-acetylgalactosamine (GalNAc) residues in O-linked glycan
112 s 61% (range, 12-95%) of the peptide alpha-N-acetylgalactosamine (GalNAc) residues to be substituted
113 complexed with beta-methyl galactoside and N-acetylgalactosamine (GalNAc) reveal that as with wild-ty
114 ve transfers of glucoronic acid (GlcA) and N-acetylgalactosamine (GalNAc) to elongate a chain consist
115  glycosylation is initiated by polypeptide N-acetylgalactosamine (GalNAc) transferase (ppGalNAcT) act
116      Our knowledge of the O-glycoproteome [N-acetylgalactosamine (GalNAc) type] is highly limited.
117 e (GlcNAc), galactose (Gal), xylose (Xyl), N-acetylgalactosamine (GalNAc), and glucose (Glc), using g
118  glycosylation containing galactose (Gal), N-acetylgalactosamine (GalNAc), and sialic acid.
119 nopeptidase N is specifically inhibited by N-acetylgalactosamine (GalNAc), suggesting that this toxin
120 , as demonstrated by the implementation of N-acetylgalactosamine (GalNAc)-conjugated ASOs for Asialog
121  silencing in the context of the trivalent N-acetylgalactosamine (GalNAc)-conjugated siRNA in mice re
122     Certain lectins recognize the terminal N-acetylgalactosamine (GalNAc)-containing O-glycans on Gal
123 ngiensis strains) lacked Gal and contained N-acetylgalactosamine (GalNAc).
124 ides that are modified with beta1,4-linked N-acetylgalactosamine (GalNAc).
125 mily of uridine 5'-diphosphate (UDP)-alpha-N-acetylgalactosamine (GalNAc):polypeptide N-acetylgalacto
126 oteins bearing terminal galactose (Gal) or N-acetylgalactosamine (GalNAc); however, endogenous ligand
127                                Mucin-type (N-acetylgalactosamine [GalNAc]-type) O-glycosylation is fo
128            A series of sialyl fucosyl poly-N-acetylgalactosamine gangliosides without the sialyl-Le e
129 oboside or P antigen is synthesized by UDP-N-acetylgalactosamine:globotriaosyl-ceramide 3-beta-N-acet
130 d group criteria and is synthesized by UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acet
131 he gene for GM2/GD2 synthase [GalNAcT (UDP-N-acetylgalactosamine:GM3/GD3 beta-1,4-N-acetylgalactosami
132 h, galactosamine, N-acetylglucosamine, and N-acetylgalactosamine had no significant effect on the par
133 n, a fourth region likely to interact with N-acetylgalactosamine has been identified and probed by si
134  structural basis for selective binding to N-acetylgalactosamine has been investigated.
135 to be important in preferential binding to N-acetylgalactosamine have been inserted into the homologo
136 transferred sulfate to the C-4 position of N-acetylgalactosamine in chondroitin and desulfated dermat
137  a binding pocket for the 2-substituent of N-acetylgalactosamine in the hepatic asialoglycoprotein re
138 hifts of amide signals from (15)N-containing acetylgalactosamines in CSs are shown to be quite sensit
139 cetylhexosamine (HexNAc), either GlcNAc or N-acetylgalactosamine, in the terminal position or, altern
140 lycosylated CD44 enhanced binding; and (d) N-acetylgalactosamine incorporation into non-N-linked glyc
141 is completely inhibited in the presence of N-acetylgalactosamine, indicating loss of domain III bindi
142 ins was identified as the 170-kD galactose/N-acetylgalactosamine-inhibitable lectin (Gal/GalNAc) usin
143 ot galactosamine, N-acetylglucosamine, and N-acetylgalactosamine inhibited the growth of the parasite
144 diate, and light subunits of the galactose-N-acetylgalactosamine-inhibitible lectin, an important cel
145 changed to valine, loss in selectivity for N-acetylgalactosamine is observed.
146                                 UDP-N-[1-14C]acetylgalactosamine is prepared by acetylation of UDP-ga
147  residues in combination with 4-O-sulfated N-acetylgalactosamine is sufficient for high affinity bind
148 y yeast hexokinase, homoserine kinase, and N-acetylgalactosamine kinase (obtained by comparison of th
149  transition state were 2.1 x 10(-16) m for N-acetylgalactosamine kinase, 7.4 x 10(-17) m for homoseri
150 using 5-azido-UTP, [gamma-32P]ATP, porcine N-acetylgalactosamine kinase, and Escherichia coli UDP-N-a
151 -acetylglucosamine and uridine diphosphate N-acetylgalactosamine, leading to the synthesis of epimeri
152                       Fecal anti-galactose/N-acetylgalactosamine lectin immunoglobulin A was associat
153 cible nitric oxide synthase, and galactose/N-acetylgalactosamine macrophage lectin, as well as TGF-be
154 NAc unit, suggesting that 4-O-sulfation at N-acetylgalactosamine may precede epimerization of glucuro
155 nitiates docking through recognition of an N-acetylgalactosamine moiety on L. dispar APN.
156  galactose, glucose, sialic acid, mannose, N-acetylgalactosamine, N-acetylglucosamine, and fucose.
157  with the terminal galactose replaced with N-acetylgalactosamine (NHAc-Pk).
158 ion, O-linked mannose (O-Man) and O-linked N-acetylgalactosamine (O-GalNAc), in its highly conserved
159 er/Thr-O-GlcNAc, alpha-linked Ser-O-linked N-acetylgalactosamine (O-GalNAc), or N-linked oligosacchar
160 mucin-related O-linked glycopeptide, alpha-N-acetylgalactosamine-O-serine/threonine (Tn), which is hi
161 nalogue PPA15(T7), glycosylated with alpha-N-acetylgalactosamine on Thr7, were prepared and investiga
162 nt have lost the ability to utilize either N-acetylgalactosamine or galactosamine as sole sources of
163 s had elevated activity in the presence of N-acetylgalactosamine or galactosamine, were regulated in
164          Enzymatic removal of the terminal N-acetylgalactosamine or galactose of A- or B-antigens, re
165 binds to glycoproteins expressing terminal N-acetylgalactosamine or galactose residues.
166 or (a structure terminated with galactose, N-acetylgalactosamine, or sialic acid).
167 mine but not by galactose, xylose, fucose, N-acetylgalactosamine, or sialic acid-containing glycoprot
168 tions appear to produce the preference for N-acetylgalactosamine over galactose and are also likely t
169 essential for establishing selectivity for N-acetylgalactosamine over galactose.
170 y distinct recombinant uridine diphosphate-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltr
171 ides over Ser peptides for the porcine UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltr
172 e ability to synthesize polyprenyl-phospho-N-acetylgalactosamine (polyprenyl-P-GalNAc) from polypreny
173 n complex with the N-acetylglucosamine and N-acetylgalactosamine products of catalysis and in complex
174 te the existence of another galactose- and N-acetylgalactosamine-recognizing lectin distinct from mMG
175 play stronger binding to galactosamine and N-acetylgalactosamine relative to d-galactose.
176 inked oligosaccharides containing terminal N-acetylgalactosamine required for [125I]Cry1Ac binding in
177 the core of these glycans is frequently an N-acetylgalactosamine residue that is alpha-linked to seri
178 e interaction of the peptide and the first N-acetylgalactosamine residue.
179 exoglycosidase that cleaves terminal alpha-N-acetylgalactosamine residues from glycopeptides and glyc
180      Each cleaved nonreducing alpha(1-->3)-N-acetylgalactosamine residues from human blood group A an
181 nt in patients with IgAN, leaving terminal N-acetylgalactosamine residues in the hinge region exposed
182 eptor binds oligosaccharides with terminal N-acetylgalactosamine residues more tightly than ligands w
183  of bulky substituents to the reducing end N-acetylgalactosamine residues of C4S dodecasaccharide had
184 e epitope recognized by 4E9 contains alpha-N-acetylgalactosamine residues, which are present in a muc
185 s a result of the presence of alpha-linked N-acetylgalactosamine residues.
186 r determination of the sulfate position on N-acetylgalactosamine residues.
187 eir glycan components contain alpha-linked N-acetylgalactosamine residues.
188 hydrate-recognition domain in complex with N-acetylgalactosamine reveals a direct interaction between
189 port that metabolic cross-talk between the N-acetylgalactosamine salvage and O-GlcNAcylation pathways
190  good as or better than that of the parent N-acetylgalactosamine, showing that modification on either
191 or the rat Kupffer cell lectin (fucose and N-acetylgalactosamine specific) adhered specifically to gl
192 erase was significantly lower, and that of N-acetylgalactosamine-specific alpha2,6-sialyltransferase
193 syltransferase activity and an increase in N-acetylgalactosamine-specific alpha2,6-sialyltransferase
194 transferase or a terminal sialic acid by a N-acetylgalactosamine-specific alpha2,6-sialyltransferase.
195 own as the mouse macrophage galactose- and N-acetylgalactosamine-specific lectin (mMGL).
196 ither patent or latent reactivity with the N-acetylgalactosamine-specific lectin Vicia villosa agglut
197 e neutralizing effect of the MAb and alpha-N-acetylgalactosamine-specific lectins strongly implicate
198 drate units that terminate with a sulfated N-acetylgalactosamine structure (GalNAc-4-SO(4)) that medi
199 ific for either N-acetylneuraminic acid or N-acetylgalactosamine, suggesting that it was composed of
200 lycan consisting of repeating uronic acid, N-acetylgalactosamine sulfate disaccharide units [-UroA(be
201 rophoresis analysis demonstrated increased N-acetylgalactosamine sulfation at both 4- and 6-carbons.
202 ctins specifically recognize galactose- or N-acetylgalactosamine-terminated oligosaccharides.
203 tal structure of the modified CRD bound to N-acetylgalactosamine, the histidine (His(202)) contacts t
204 r the discrimination between galactose and N-acetylgalactosamine, the substrate transferred by GTA.
205 s convert added peracetylated benzyl-alpha-N-acetylgalactosamine to a large variety of modified O-gly
206 ages joining either N-acetylglucosamine or N-acetylgalactosamine to a wide variety of aglycon residue
207  structures showed N-acetylglucosamine and N-acetylgalactosamine to be recognized via identical sets
208 ferred galactose, N-acetylglucosamine, and N-acetylgalactosamine to carbohydrate, glycoprotein, and g
209 ensation of undecaprenyl phosphate and UDP-N-acetylgalactosamine to generate undecaprenyl phosphate-N
210 rabinose, fucose, methyl galacturonate and N-acetylgalactosamine to give the corresponding peracetyla
211 nant EXTL2 showed weak ability to transfer N-acetylgalactosamine to heparan sulfate precursor molecul
212 dification of glycans by beta4 addition of N-acetylgalactosamine to N-acetylglucosamine with formatio
213 o incorporation of N-acetylglucosamine and N-acetylgalactosamine to oligosaccharide acceptors resembl
214 inst Anln messenger RNA were conjugated to N-acetylgalactosamine to reduce toxicity and increase hepa
215                            The addition of N-acetylgalactosamine to Ser71, Thr72, Thr75, and Thr139 l
216 e acetyl group from undecaprenyl phosphate-N-acetylgalactosamine to yield undecaprenyl phosphate-beta
217 ynthase K4CP catalyzes glucuronic acid and N-acetylgalactosamine transfer activities and polymerizes
218 sequence abolishes glucuronic acid but not N-acetylgalactosamine transfer activity in K4CP.
219                            The polypeptide N-acetylgalactosamine transferase-1 (ppGalNAcT-1) initiate
220 lasmic reticulum relocation of polypeptide N-acetylgalactosamine-transferases (GalNAc-Ts) drives high
221  purified the rat liver Golgi membrane UDP-N-acetylgalactosamine transporter.
222                      Here we show that the N-acetylgalactosamine-type O-glycosylation enzyme GALNT11
223 ein, shows UDP-GlcNAcA 4-epimerase and UDP-N-acetylgalactosamine (UDP-GalNAc) 4-epimerase activities.
224 P-N-acetylglucosamine (UDP-GlcNAc) and UDP-N-acetylgalactosamine (UDP-GalNAc) transport in Arabidopsi
225 ratio of UDP-GlcNAc to uridine diphosphate-N-acetylgalactosamine (UDP-GalNAc), irrespective of the in
226 type transporter, whereas transport of UDP-N-acetylgalactosamine was decreased by 85-90%, resulting i
227 TTST(GalNAc)TSAP (where GalNAc is O-linked N-acetylgalactosamine), were shown to coelute following re
228 , composed mainly of galacturonic acid and N-acetylgalactosamine, were characterised for the first ti
229 ed on these results and the orientation of N-acetylgalactosamine when bound to an homologous galactos
230 , however, did not form 4, 6-di-O-sulfated N-acetylgalactosamine when chondroitin sulfate C was used
231 on Thr(402) with an N-acetylglucosamine or N-acetylgalactosamine, whereas Ser(692) remained unmodifie
232 , which inhibit membrane interactions, and N-acetylgalactosamine, which targets asialoglycoprotein re
233                                            N-Acetylgalactosamine yielded two major peaks, which were

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top